ClinicalTrials.gov
public full text
Public Domain
Comparison of Epzicom and Truvada for the Initial Once Daily HIV Treatment
A non-inferiority randomized control trial in treatment naïve HIV patients to compare virologic effect of two backbone regimens with Epzicom (lamivudine and abacavir) and Truvada (emtricitabine and tenofovir). Both arms are treated with fixed combination of ritonavir boosted atazanavir as key drugs.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Simple Once Daily Triple Regimen Including Tenofovir, Emtricitabine and Efavirenz in HIV-1 Infected Patients (ANRS 1207)#1195581
- Daclizumab to Treat HIV-Infected Patients#830283
- Clinical outcomes of HIV treatment clients enrolled in six-month dispensing after less than 6 months on treatment in Zambia: A target trial emulation#623306
- HIV-1-Gag Conserved-Element DNA Vaccine (p24CE) Vaccine Study#912819
- Kaposi Sarcoma Chemotherapy and Research (KS-CARE)#897976
Record · ID 1396659
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive